Anthrax

Anesthesiology Clinics of North America

Volumn 22, Issue 3, 2004, Pages 533-540

  Gruber Kalamas, Alicia ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTHRAX VACCINE; ANTIBIOTIC AGENT; CEPHALOSPORANIC ACID DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; DOXYCYCLINE; IMIPENEM; PENICILLIN G; RIFAMPICIN; SULFAMETHOXAZOLE; TRIMETHOPRIM; VANCOMYCIN;

AEROSOL; ANTHRAX; ANTIBIOTIC RESISTANCE; BACILLUS ANTHRACIS; BACTERIAL SPORE; CLINICAL FEATURE; CORRELATION ANALYSIS; DIAGNOSTIC TEST; FEASIBILITY STUDY; GASTROINTESTINAL ANTHRAX; GRAM STAINING; HUMAN; INFECTION CONTROL; INHALATIONAL ANTHRAX; INTENSIVE CARE; LETHALITY; MEDICAL RESEARCH; MICROBIOLOGY; MILITARY PHENOMENA; NONHUMAN; PATHOGENESIS; REVIEW; SKIN ANTHRAX; SPUTUM CULTURE; THORAX RADIOGRAPHY; UNITED STATES;

ANTHRAX; HUMANS;

EID: 4344646566     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atc.2004.05.009     Document Type: Review

References (24)

1. Dixon T.C., Meselson M., Guillemin J., Hanna P.C. Anthrax. N Engl J Med. 341:1999;815-826
2. Ingelsby T.V., O'Tode T., Henderson D.A., Bartlett J.G., Ascher M.S., et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 287:2002;2236-2252
3. Quintiliani R. Jr., Quintiliani R. Inhalational anthrax and bioterrorism. Curr Opin Pulm Med. 9:2003;221-226
4. Bartlett J.G., Ingelsby T.V. Jr., Borio L Management of anthrax. Clin Infect Dis. 35:2002;851-858
5. Cole L.A. The specter of biological weapons. Sci Am. 275:1996;60-65
6. Meselson M., Guillemin J., Hugh-Jones M., Langmuir A., Popova I., Shelokova A., et al. The Sverdlovsk anthrax outbreak of 1979. Science. 266:1994;1202-1208
7. Zalinskas R.A. Iraq's biological weapons: the past as the future. JAMA. 278:1997;418-424
8. Ingelsby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Friedlander A.M., et al. Anthrax as a biological weapon. JAMA. 281:1999;1735-1745
9. Office of Technology Assessment US Congress Proliferation of weapons of mass destruction. 1993;US Government Printing Office, Washington, DC
10. Bradley P.J., Ferlito A., Brandwein M.S., Benninger M.S., Rinaldo A. Anthrax: what should the otolaryngologist know? Acta Otolaryngol. 122:2002;580-585
11. Williams R.P. Bacillus anthracis and other spore forming bacilli. Braude A.I., Davis L.E., Fierer J. Infectious disease and medical microbiology. 1986;270-278 WB Saunders, Philadelphia
12. Hatch T.F. Distribution and deposition of inhaled particles in respiratory tract. Bacteriol Rev. 25:1961;237-240
13. Guidi-Rontani C., Weber-Levy M., Labruyere E., Mock M. Germination of Bacillus anthracis spores withion alveolar macrophages. Mol Microbiol. 31:1999;9-17
14. Jernigan J.A., Stephens D.S., Ashford D.A., Omenaca C., Topiel M.S., Galbraith M., et al. Bioterrorism-related anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 7:2001;933-944
15. Amramova F.A., Grinberg L.M., Yampolskaya O., Walker D.H. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak in 1979. Proc Natl Acad Sci U S A. 90:1993;2291-2294
16. Quintiliani R. Jr., Quintiliani R. Fatal case of inhalational anthrax mimicking intra-abdominal sepsis. Conn Med. 66:2002;261-267
17. Karwa M., Bronzert P., Kvetan V. Bioterrorism and critical care. Crit Care Clin. 19:2003;279-313
18. Smego R.A. Jr., Gebrian B., Desmangels G. Cutaneous manifestations of anthrax in rural Haiti. Clin Infect Dis. 26:1998;97-102
19. LaForce F.M. Anthrax. Clin Infect Dis. 19:1994;1009-1014
20. Tekin A., Bulut N., Unal T. Acute abdomen due to anthrax. Br J Surg. 84:1997;813
21. Friedlander A. Anthrax. Zajtchuk R., Bellamy R.F. Textbook of military medicine: medical aspects of chemical and biological warfare. 1997;467-478 Office of the Surgeon General, US Department of the Army, Washington, DC
22. Centers for Disease Control and Prevention Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep. 50:2001;909-919
23. Centers for Disease Control and Prevention Additional options for preventative treatment for exposed persons to inhalation anthrax. JAMA. 287:2002;579
24. Centers for Disease Control and Prevention Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 51:2002;1024-1026